Logo image of QBTS

D-WAVE QUANTUM INC (QBTS) Stock Fundamental Analysis

NYSE:QBTS - New York Stock Exchange, Inc. - US26740W1099 - Common Stock - Currency: USD

7.25  -0.14 (-1.89%)

After market: 7.2198 -0.03 (-0.42%)

Fundamental Rating

2

QBTS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. QBTS may be in some trouble as it scores bad on both profitability and health. QBTS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

QBTS had negative earnings in the past year.
QBTS had a negative operating cash flow in the past year.
QBTS Yearly Net Income VS EBIT VS OCF VS FCFQBTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of QBTS (-148.94%) is worse than 93.84% of its industry peers.
Industry RankSector Rank
ROA -148.94%
ROE N/A
ROIC N/A
ROA(3y)-142.44%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QBTS Yearly ROA, ROE, ROICQBTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 500 -500 -1K

1.3 Margins

Looking at the Gross Margin, with a value of 64.27%, QBTS is in line with its industry, outperforming 44.20% of the companies in the same industry.
QBTS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for QBTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.79%
GM growth 5YN/A
QBTS Yearly Profit, Operating, Gross MarginsQBTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -200 -400 -600 -800

More info and screens

1

2. Health

2.1 Basic Checks

QBTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, QBTS has more shares outstanding
Compared to 1 year ago, QBTS has a worse debt to assets ratio.
QBTS Yearly Shares OutstandingQBTS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 50M 100M 150M
QBTS Yearly Total Debt VS Total AssetsQBTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

QBTS has an Altman-Z score of 0.94. This is a bad value and indicates that QBTS is not financially healthy and even has some risk of bankruptcy.
QBTS has a Altman-Z score of 0.94. This is in the lower half of the industry: QBTS underperforms 65.58% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.94
ROIC/WACCN/A
WACC12.71%
QBTS Yearly LT Debt VS Equity VS FCFQBTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

QBTS has a Current Ratio of 1.36. This is a normal value and indicates that QBTS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.36, QBTS is in line with its industry, outperforming 42.39% of the companies in the same industry.
QBTS has a Quick Ratio of 1.28. This is a normal value and indicates that QBTS is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.28, QBTS perfoms like the industry average, outperforming 40.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.28
QBTS Yearly Current Assets VS Current LiabilitesQBTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 41.94% over the past year.
QBTS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.23%.
Measured over the past years, QBTS shows a quite strong growth in Revenue. The Revenue has been growing by 19.28% on average per year.
EPS 1Y (TTM)41.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
Revenue 1Y (TTM)14.23%
Revenue growth 3Y19.28%
Revenue growth 5YN/A
Sales Q2Q%-27.01%

3.2 Future

QBTS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.09% yearly.
The Revenue is expected to grow by 56.62% on average over the next years. This is a very strong growth
EPS Next Y45.99%
EPS Next 2Y26.48%
EPS Next 3Y18.25%
EPS Next 5Y14.09%
Revenue Next Year-15.16%
Revenue Next 2Y17.97%
Revenue Next 3Y43.89%
Revenue Next 5Y56.62%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
QBTS Yearly Revenue VS EstimatesQBTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
QBTS Yearly EPS VS EstimatesQBTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

QBTS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year QBTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QBTS Price Earnings VS Forward Price EarningsQBTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QBTS Per share dataQBTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3

4.3 Compensation for Growth

QBTS's earnings are expected to grow with 18.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.48%
EPS Next 3Y18.25%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QBTS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

D-WAVE QUANTUM INC

NYSE:QBTS (2/21/2025, 8:04:01 PM)

After market: 7.2198 -0.03 (-0.42%)

7.25

-0.14 (-1.89%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)05-12 2025-05-12/bmo
Inst Owners52.59%
Inst Owner Change7.84%
Ins Owners1.36%
Ins Owner Change2.6%
Market Cap2.25B
Analysts81.82
Price Target7.34 (1.24%)
Short Float %15.02%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.16%
Min EPS beat(2)-0.88%
Max EPS beat(2)0.56%
EPS beat(4)2
Avg EPS beat(4)-5.31%
Min EPS beat(4)-26.05%
Max EPS beat(4)5.12%
EPS beat(8)3
Avg EPS beat(8)-14.59%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26%
Min Revenue beat(2)-27.66%
Max Revenue beat(2)-24.33%
Revenue beat(4)0
Avg Revenue beat(4)-28.23%
Min Revenue beat(4)-39.75%
Max Revenue beat(4)-21.2%
Revenue beat(8)0
Avg Revenue beat(8)-23.4%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)42.57%
PT rev (3m)174.29%
EPS NQ rev (1m)16.26%
EPS NQ rev (3m)12.71%
EPS NY rev (1m)-5.21%
EPS NY rev (3m)3.39%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-39.61%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-10.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 238.74
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0.03
BVpS-0.05
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -148.94%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.27%
FCFM N/A
ROA(3y)-142.44%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.79%
GM growth 5YN/A
F-Score4
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 157.92%
Cap/Sales 17.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.28
Altman-Z 0.94
F-Score4
WACC12.71%
ROIC/WACCN/A
Cap/Depr(3y)75.23%
Cap/Depr(5y)N/A
Cap/Sales(3y)15.34%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
EPS Next Y45.99%
EPS Next 2Y26.48%
EPS Next 3Y18.25%
EPS Next 5Y14.09%
Revenue 1Y (TTM)14.23%
Revenue growth 3Y19.28%
Revenue growth 5YN/A
Sales Q2Q%-27.01%
Revenue Next Year-15.16%
Revenue Next 2Y17.97%
Revenue Next 3Y43.89%
Revenue Next 5Y56.62%
EBIT growth 1Y13.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1.64%
EBIT Next 3Y4.67%
EBIT Next 5Y13.71%
FCF growth 1Y13.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.06%
OCF growth 3YN/A
OCF growth 5YN/A